minerva surgical inc - UTRS

UTRS

Close Chg Chg %
0.00 0.00 0.00%

Closed Market

0.00

0.00 (0.00%)

Volume: 208.00

Last Updated:

Dec 30, 2025, 9:58 AM EDT

Company Overview: minerva surgical inc - UTRS

UTRS Key Data

Open

$0.00

Day Range

0.00 - 0.00

52 Week Range

0.00 - 0.00

Market Cap

$0.00

Shares Outstanding

8.88M

Public Float

961.31K

Beta

82.22

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$23.71

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

544.50

 

UTRS Performance

1 Week
 
0.00%
 
1 Month
 
-90.00%
 
3 Months
 
0.00%
 
1 Year
 
-100.00%
 
5 Years
 
N/A
 

UTRS Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About minerva surgical inc - UTRS

Minerva Surgical, Inc. engages in the research, development, manufacture, and commercialization of invasive solutions for uterine healthcare needs of women. It offers therapeutic devices for abnormal uterine bleeding treatment. The company was founded by Csaba Truckai in 2008 and is headquartered in Santa Clara, CA.

UTRS At a Glance

Minerva Surgical, Inc.
4255 Burton Drive
Santa Clara, California 95054
Phone 1-855-646-7874 Revenue 50.29M
Industry Medical Specialties Net Income -34,112,000.00
Sector Health Technology Employees 174
Fiscal Year-end 12 / 2023
View SEC Filings

UTRS Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.128
Price to Book Ratio 0.388
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -1.351
Enterprise Value to Sales 0.767
Total Debt to Enterprise Value 1.029

UTRS Efficiency

Revenue/Employee 289,045.977
Income Per Employee -196,045.977
Receivables Turnover 6.943
Total Asset Turnover 0.547

UTRS Liquidity

Current Ratio 2.53
Quick Ratio 1.35
Cash Ratio 0.529

UTRS Profitability

Gross Margin 37.253
Operating Margin -79.518
Pretax Margin -67.803
Net Margin -67.825
Return on Assets -37.08
Return on Equity -111.323
Return on Total Capital -59.981
Return on Invested Capital -49.505

UTRS Capital Structure

Total Debt to Total Equity 231.011
Total Debt to Total Capital 69.79
Total Debt to Total Assets 57.605
Long-Term Debt to Equity 217.921
Long-Term Debt to Total Capital 65.835
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Minerva Surgical Inc - UTRS

Collapse All in section
All values USD millions. 2019 2020 2021 2022 5-year trend
Sales/Revenue
26.01M 37.77M 52.10M 50.29M
Sales Growth
- +45.19% +37.96% -3.47%
Cost of Goods Sold (COGS) incl D&A
14.38M 24.12M 30.10M 31.56M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
1.68M 7.08M 10.62M 11.43M
Depreciation
1.68M 2.00M 2.40M 3.22M
Amortization of Intangibles
- 5.08M 8.22M 8.21M
COGS Growth
- +67.74% +24.77% +4.84%
Gross Income
11.63M 13.64M 22.00M 18.74M
Gross Income Growth
- +17.32% +61.27% -14.85%
Gross Profit Margin
+44.71% +36.13% +42.23% +37.25%
2019 2020 2021 2022 5-year trend
SG&A Expense
31.27M 28.21M 50.72M 58.73M
Research & Development
935.00K 3.32M 5.29M 5.44M
Other SG&A
30.33M 24.89M 45.43M 53.29M
SGA Growth
- -9.78% +79.80% +15.79%
Other Operating Expense
- - - -
-
Unusual Expense
14.95M (7.55M) (19.65M) (9.09M)
EBIT after Unusual Expense
(34.59M) (7.02M) (9.07M) (30.90M)
Non Operating Income/Expense
119.00K 762.00K (658.00K) 20.00K
Non-Operating Interest Income
135.00K 81.00K 10.00K 89.00K
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
17.58M 12.14M 11.73M 3.22M
Interest Expense Growth
- -30.94% -3.39% -72.53%
Gross Interest Expense
17.58M 12.14M 11.73M 3.22M
Interest Capitalized
- - - -
-
Pretax Income
(52.05M) (18.39M) (21.45M) (34.10M)
Pretax Income Growth
- +64.66% -16.63% -58.94%
Pretax Margin
-200.08% -48.71% -41.18% -67.80%
Income Tax
- (132.00K) 9.00K 11.00K
Income Tax - Current - Domestic
- - - -
-
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(52.05M) (18.26M) (21.46M) (34.11M)
Minority Interest Expense
- - - -
-
Net Income
(52.05M) (18.26M) (21.46M) (34.11M)
Net Income Growth
- +64.91% -17.53% -58.93%
Net Margin Growth
-200.08% -48.36% -41.20% -67.83%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(52.05M) (18.26M) (21.46M) (34.11M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(52.05M) (18.26M) (21.46M) (34.11M)
EPS (Basic)
-35.2788 -12.3794 -14.894 -23.682
EPS (Basic) Growth
- +64.91% -20.31% -59.00%
Basic Shares Outstanding
1.48M 1.48M 1.44M 1.44M
EPS (Diluted)
-35.2788 -12.3794 -14.894 -23.682
EPS (Diluted) Growth
- +64.91% -20.31% -59.00%
Diluted Shares Outstanding
1.48M 1.48M 1.44M 1.44M
EBITDA
(17.96M) (7.49M) (18.10M) (28.56M)
EBITDA Growth
- +58.31% -141.66% -57.82%
EBITDA Margin
-69.05% -19.83% -34.74% -56.79%

Minerva Surgical Inc in the News